4D Molecular Therapeutics, Inc. (FDMT) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Viking Global Investors LP entity

10% owner

$38.90M (2)

$10.55M (1)

+$28.35M

8,185,828

14.83%

$105.11M

+107.9%

David Kirn

See Remarks

—

$13.28M (30) scheduled

−$13.28M

1,309,153

2.37%

$16.81M

−34.5%

Tony Dung Ling Yao

Director

$9.78M (1)

—

+$9.78M

1,063,744

1.93%

$13.66M

—

David Schaffer

Director

—

$3.01M (13)

−$3.01M

901,215

1.63%

$11.57M

−9.9%

John F Milligan

Director

$2.30M (1)

—

+$2.30M

100,000

0.1811%

$1.28M

—

Scott Bizily

Chief Legal Officer

—

$1.93M (43) scheduled

−$1.93M

8,617

0.0156%

$110.64K

−46.6%

Robert Young Kim

Chief Medical Officer

—

$737.79K (4) scheduled

−$737.79K

1,043

0.0019%

$13.39K

−34.6%

Jacob Chacko

Director

—

$100.27K (1) scheduled

−$100.27K

0

0.0000%

$0.00

—

Fariborz Kamal

President & COO

$99.98K (1)

—

+$99.98K

4,347

0.0079%

$55.82K

—

Ashoo Gupta

VP, Finance and Controller

—

$6.73K (4) scheduled

−$6.73K

47,055

0.0852%

$604.19K

+3.1%

Ra Capital Management, L.p. entity

10% owner

—

4,563,211

8.26%

$58.59M

−10.5%

Bvf Partners L P/Il entity

See Explanation of Responses

—

87,911

0.1592%

$1.13M

−98.5%

Charles Theuer

Director

—

41,684

0.0755%

$535.22K

+28.8%

August J Moretti

Chief Financial Officer

—

11,045

0.0200%

$141.82K

+173.1%

4D Molecular Therapeutics, Inc.

What the insiders did Net buying

By person